There were 564 press releases posted in the last 24 hours and 171,498 in the last 365 days.

A1 Slim by Kiriko : Recall - Undeclared Drug Ingredients

[Posted 10/06/2017]

AUDIENCE: Consumer

ISSUE: Kiriko, LLC. is voluntarily recalling all lots of A1 Slim 30 capsules bottle to the consumer level.  FDA laboratory analysis has found the A1 Slim product to be tainted with sibutramine, phenolphthalein and N-Desmethyl sibutramine.

These undeclared ingredients make this product an unapproved new drug for which safety and efficacy have not been established; therefore, subject to recall.

Sibutramine is an appetite suppressant that was withdrawn from the U.S. market in October 2010 due to safety concerns.  N-Desmethyl sibutramine is an active metabolite of sibutramine.  Sibutramine and its active metabolites substantially increase blood pressure and/or pulse rate in some patients and may present a significant risk for patients with a history of coronary artery disease, congestive heart failure, arrhythmias or stroke.Phenolphthalein was previously used in over-the-counter laxatives, but because of concerns of carcinogenicity, it is no longer marketed in the U.S. 

BACKGROUND: This tainted product is marketed as a weight loss dietary supplement and is packaged in a white plastic bottle containing 30 capsules with a white screw-on cap, barcode A105212014.  The recall includes all lots of A1 Slim remaining within expiry.  The product was distributed Nationwide via retail stores in Houston, TX and by mail-order (December 6, 2016-May 1, 2017).

RECOMMENDATION: A1 Slim is notifying its distributors and customers by telephone and mail and is arranging for return of all recalled products.  Consumers and retailers that have A1 Slim which is being recalled should stop using and return the product to the place of purchase.

Consumers with questions regarding this recall can contact Kiriko, LLC. by phone at 832-228-3613 or e-mail at kirikosolution@gmail.com on Monday-Friday, 8:00 AM to 4:30 PM, CST.  Consumers should contact their physician or healthcare provider if they have experienced any problems that may be related to taking or using this drug product.

 

Healthcare professionals and patients are encouraged to report adverse events or side effects related to the use of these products to the FDA's MedWatch Safety Information and Adverse Event Reporting Program:

  • Complete and submit the report Online: www.fda.gov/MedWatch/report
  • Download form or call 1-800-332-1088 to request a reporting form, then complete and return to the address on the pre-addressed form, or submit by fax to 1-800-FDA-0178

 

[10/05/2017 - Recall Notice - Kiriko, LLC]

Distribution channels: Healthcare & Pharmaceuticals Industry